Lu, S., Ye, M., Ding, L., Tan, F., Fu, J., & Wu, B. (2016). Cost-effectiveness of gefitinib, icotinib, and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China. Oncotarget.
Stile di citazione ChicagoLu, Shun, Ming Ye, Lieming Ding, Fenlai Tan, Jie Fu, e Bin Wu. "Cost-effectiveness of Gefitinib, Icotinib, and Pemetrexed-based Chemotherapy As First-line Treatments for Advanced Non-small Cell Lung Cancer in China." Oncotarget 2016.
Citazione MLALu, Shun, et al. "Cost-effectiveness of Gefitinib, Icotinib, and Pemetrexed-based Chemotherapy As First-line Treatments for Advanced Non-small Cell Lung Cancer in China." Oncotarget 2016.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.